The role and place of the health related quality of life in the modern management of lung cancer patients
Journal Title: OncoReview - Year 2011, Vol 1, Issue 4
Abstract
Quality of life is a personal perception of the individual position held in the life, within the context of culture and value system and in relation to their objectives, expectations and worries. Patients perceptions of quality of life is changing during the treatment, taking into account the aspect of the disease. Diagnostic capabilities and the results of oncological treatment have been improving, consequently the health-related quality of life becomes more and more important. Surgical methods in lung cancer patients are associated with decreased of quality of life, particularly in the perioperative period and shortly after surgery. The addition of chemotherapy or radiation after surgery therapy does not reduce the quality of life of these patients. The main aim of chemotherapy is a reduction or relief of symptoms associated with cancer, obtaining objective response, prolonged survival, as well as improving the quality of life. Lung cancer patients assess their quality of life lower than healthy individuals. Multidrug chemotherapy based on platinum, as well as new targeted molecular methods, improve the general quality of life, but in this area prospective and randomized trials, take account not only aspects of the objective, but subjective illness as well. Research on subjective aspects of the disease are becoming more and more interesting, and initial studies suggest that temperament traits and selected strategies for coping with the disease might be related, and even influence the therapeutic process, as well as be predictors of treatment outcome, no doubt enhancing the health-relatedquality of life.
Authors and Affiliations
Anna Kieszkowska-Grudny
Keywords
Related Articles
- EP ID EP53119
- DOI -
- Views 228
- Downloads 0
PTEN – clinical significance in colorectal cancer
Phosphatase and tensin homolog deleted on chromosome ten (PTEN ) is a human suppressor gene. Its protein product is a bispecific phosphatase playing the complex role in the cell cycle regulating processes and apoptosis b...
Cardiac amyloidosis: a hidden cause of cardiovascular complications in oncology practice
Amyloidosis is rare, but known cause of heart failure, cardiomyopathy, coronary artery disease, disorders of cardiac conduction system and valvular damage. Disease often remains undetected until it reaches an advanced st...
Treatment of patients with multiple myeloma than 65–70 years of age and the role of maintenance therapy after transplantation stem cells
Treatment of myeloma has changed significantly in the past decade as results of better understanding of disease biology, more effective treatments, and improved supportive care. Autologous stem cell transplantation (SCT)...
Nowe możliwości leczenia uogólnionego raka piersi
Mimo udoskonalania metod badań przesiewowych, wczesnego wykrywania raka piersi i nowych terapii rokowanie w raku piersi pozostaje złe. Zaawansowany, uogólniony rak piersi jest chorobą przewlekłą, nieuleczalną. Podstawową...
Cardio-oncology: What is the future?